The Rise of Superbugs: A Comprehensive Review of Antimicrobial Resistance Mechanisms and Management

The rapid emergence and global spread of antimicrobial-resistant microorganisms—commonly termed “superbugs”—pose a critical threat to public health, modern medicine, and global economies. This integrated review examines the multidimensional factors driving antimicrobial resistance (AMR), including microbial evolution, misuse and overuse of antibiotics in humans and animals, inadequate infection control, and environmental dissemination of resistance genes. Key pathogens such as MRSA, VRE, CRE, ESBL-producing Enterobacteriaceae, and drug-resistant Mycobacterium tuberculosis are discussed in terms of their epidemiology, mechanisms of resistance, and clinical impact. The review also highlights the role of horizontal gene transfer, mobile genetic elements, and biofilms in accelerating resistance. Current diagnostic challenges, treatment limitations, and the socio-economic implications of AMR are explored. Finally, emerging solutions—including rapid diagnostics, antimicrobial stewardship, novel drug discovery, bacteriophage therapy, probiotics, vaccines, and global policy initiatives—are evaluated. This comprehensive synthesis underscores the urgent need for coordinated global action to control the rise of superbugs and safeguard the effectiveness of existing antimicrobials.

Antimicrobial resistance (AMR), Superbugs, MRSA, VRE

1. Aslam B, Wang W, Arshad MI et al (2018) Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist 11:1645. https://doi.org/10.2147/IDR.S173867 [Google Scholar] [Crossref]

2. Baptista PV, McCusker MP, Carvalho A, Ferreira DA, Mohan NM, Martins M, Fernandes AR. Nano-strategies to fight multidrug resistant bacteria—“A Battle of the Titans”. Front Microbiol. 2018;9:1441. doi: 10.3389/fmicb.2018.01441. [DOI] [PMC free article] [PubMed] [Google Scholar] [Google Scholar] [Crossref]

3. Bipin Puri 1, Raju Vaishya 2, Abhishek Vaish (2025). Antimicrobial resistance: Current challenges and future directions. Med J Armed Forces India, 81(3):247-258. doi: 10.1016/j.mjafi.2024.07.006. Epub 2024 Sep 19. [Google Scholar] [Crossref]

4. De Gaetano GV, Lentini G, Fama A, et al. Antimicrobial resistance: two-component regulatory systems and multidrug efflux pumps. Antibiotics. 2023;12:965. [Google Scholar] [Crossref]

5. Dellit TH (2007) Infectious diseases society of america and the society for healthcare epidemiology of america guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Dis Clin Pract 15:263–264. https://doi.org/10.1097/IPC.0b013e318068b1c0 [Google Scholar] [Crossref]

6. Dever LA, Dermody TS (1991) Mechanisms of bacterial resistance to antibiotics. Arch Intern Med 151:886–895. https://doi.org/10.1001/archinte.1991.00400050040010 [Google Scholar] [Crossref]

7. Dharmaratne MP, Manoraj A, Thevanesam V, Ekanayake A, Kumar NS, Liyanapathirana V, Abeyratne E, Bandara BR. Terminalia bellirica fruit extracts: in-vitro antibacterial activity against selected multidrug-resistant bacteria, radical scavenging activity and cytotoxicity study on BHK-21 cells. BMC Complement Altern Med. 2018;18(1):1–2. doi: 10.1186/s12906-018-2382-7. [DOI] [PMC free article] [PubMed] [Google Scholar] [Google Scholar] [Crossref]

8. Dilip Chandrasekhar d, ChristyMary Joseph, JafferChalil parambil , Sarath Mural, Mohammed Yahiya, Shafeera K (2024). Superbugs: An invicible threat in post antibiotic era. Clinical Epidemiology and Global Health, 28, 101499 [Google Scholar] [Crossref]

9. Eraikhuemen N, Julien D, Kelly A, Lindsay T, Lazaridis D. Treatment of community-acquired pneumonia: a focus on lefamulin. Infect Dis Ther. 2021 doi: 10.1007/s40121-020-00378-3. [DOI] [PMC free article] [PubMed] [Google Scholar] [Google Scholar] [Crossref]

10. Frieden T (2013) Antibiotic resistance threats in the United States. Centers Dis Control Prev, 114. [Google Scholar] [Crossref]

11. Gabrielyan L, Hakobyan L, Hovhannisyan A, Trchounian A. Effects of iron oxide (Fe3O4) nanoparticles on Escherichia coli antibiotic-resistant strains. J Appl Microbiol. 2019;126(4):1108–1116. doi: 10.1111/jam.14214. [DOI] [PubMed] [Google Scholar] [Google Scholar] [Crossref]

12. Global Risks (2013) Global Risks 2013 Eighth Edition an initiative of the risk response network insight report. Health Sci Rep, 6(8):1480. doi: 10.1002/hsr2.1480. https://my.clevelandclinic.org/health/diseases/superbug [Google Scholar] [Crossref]

13. https://www.who.int/en/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed [Google Scholar] [Crossref]

14. Ishan Thakar and Khushbu Patel (2025). Superbugs: Understanding the mechanisms and consequences of antibiotic resistance. IJPPS; 7(1): 45-49. DOI: https://doi.org/10.33545/26647222.2025.v7.i1a.150 [Google Scholar] [Crossref]

15. Kardos N, Demain A. Penicillin: the medicine with the greatest impact on therapeutic outcomes. Appl Microbiol Biotechnol. 2011;92(4):677-87. [Google Scholar] [Google Scholar] [Crossref]

16. Kunz AN, Brook I. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy. 2010;56:492-500. [Google Scholar] [Crossref]

17. Levy SB, Miller RV. Gene Transfer in the Environment. McGraw Hill, New York; c1989. [Google Scholar] [Crossref]

18. Levy SB. Ecology of plasmids and unique DNA sequences. In: Halvorson HO, Pramer D, Rogul M, editors. Engineered Organisms in the Environment: Scientific Issues. Washington DC: ASM Press; c1985. p. 180-90. [Google Scholar] [Crossref]

19. Levy SB. The Antibiotic Paradox: How Misuse of Antibiotics Destroys Their Curative Powers. Perseus, Cambridge; c2002. [Google Scholar] [Crossref]

20. Livermore DM, Woodford N. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 2006;14(9):413-420. [Google Scholar] [Crossref]

21. Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infec. 2012;18(3):268-81. [Google Scholar] [Google Scholar] [Crossref]

22. Medina E, Pieper D. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Curr Top Microbiol Immunol. 2016;398:3-33. [Google Scholar] [Google Scholar] [Crossref]

23. Michael CA, Dominey-Howes D, Labbate M (2014) The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. https://doi.org/10.3389/fpubh.2014.00145 [Google Scholar] [Crossref]

24. Padhy A, Sahu AR, Ranabijuli S, Ganguly S. Superbug, an emerging global threat in current scenario: A review. Int J Res Stud Microbiol Biotechnol. 2016;2(2):15-19. [Google Scholar] [Crossref]

25. Palomino JC, Martin A. Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics. 2014;3:317-340. [Google Scholar] [Crossref]

26. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010;362(19):1804-1813. [Google Scholar] [Crossref]

27. Rajendran R. Superbug information. World J Pharm Res. 2022;7(6):275-287. [Google Scholar] [Crossref]

28. Reygaert WC (2018) An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol 4:482–501. https://doi.org/10.3934/MICROBIOL.2018.3.482 [Google Scholar] [Crossref]

29. Rohatgi A, Gupta P. Natural and synthetic plant compounds as anti-biofilm agents against Escherichia coli O157: H7 biofilm. Infect Genet Evol. 2021;95:105055. doi: 10.1016/j.meegid.2021.105055. [DOI] [PubMed] [Google Scholar] [Google Scholar] [Crossref]

30. Rossolini GM, Arena F, Pecile P, Pollini S (2014) Update on the antibiotic resistance crisis. Curr Opin Pharmacol 18:56–60. https://doi.org/10.1016/J.COPH.2014.09.006 [Google Scholar] [Crossref]

31. Sakshi Painuli, Prabhakar Semwal, Rohit Sharma, Shopnil Akash (2023). Superbugs or multidrug resistant microbes: A new threat to the society. [Google Scholar] [Crossref]

32. Sengupta S, Chattopadhyay MK, Grossart HP (2013) The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol. https://doi.org/10.3389/FMICB.2013.00047 [Google Scholar] [Crossref]

33. Spellberg B, Gilbert DN (2014) The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clin Infect Dis 59:S71. https://doi.org/10.1093/CID/CIU392 [Google Scholar] [Crossref]

34. Spellberg B, Srinivasan A, Chambers HF (2016) New societal approaches to empowering antibiotic stewardship. JAMA J Am Med Assoc 315:1229–1230 [Google Scholar] [Crossref]

35. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P. Antimicrobial resistance. BMJ. 1998;317(7159):609-10. [Google Scholar] [Google Scholar] [Crossref]

36. World Health Organization (2014) Antimicrobial resistance: global report on surveillance. http://www.who.int/drugresistance/documents/surveillancereport/en/ [Google Scholar] [Crossref]

37. Wright G. Resisting resistance: Resisting resistance: new chemical strategies for battling super bugschemical strategies for battling superbugs. Chem Biol. 2000;7(6):127-32. [Google Scholar] [Google Scholar] [Crossref]

• Quantitative Assessment of Serum C - Reactive Protein Levels among Smokers and Non Smokers
• Extraction and Characterization of Eco-Friendly Hair Dye from Agricultural Waste: A Study on Coconut Husk
• Intermittent Preventive Treatment among Pregnant Women Attending a Tertiary Healthcare Facility in Jos, North Central Nigeria: Adherence Patterns and Preliminary Assessment of Associated Factors
• Assessment Of Degradative Potentials Of Bacteria Isolated From Palm Oil-Polluted Site Using Spectrophotometric Method
• An Analysis of Machine and Deep Learning Insights on the Use of Artificial Intelligence in Oral and Maxillofacial Pathology